Opyl Ltd
ASX:OPL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Opyl Ltd
Operating Income
Opyl Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Opyl Ltd
ASX:OPL
|
Operating Income
-AU$2.8m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-19%
|
|
|
Iress Ltd
ASX:IRE
|
Operating Income
AU$86.7m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
1%
|
|
|
WiseTech Global Ltd
ASX:WTC
|
Operating Income
AU$329m
|
CAGR 3-Years
3%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
TechnologyOne Ltd
ASX:TNE
|
Operating Income
AU$173.5m
|
CAGR 3-Years
15%
|
CAGR 5-Years
16%
|
CAGR 10-Years
15%
|
|
|
Linius Technologies Ltd
ASX:LNU
|
Operating Income
-AU$4.9m
|
CAGR 3-Years
20%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-31%
|
|
|
Iris Energy Ltd
NASDAQ:IREN
|
Operating Income
$26.5m
|
CAGR 3-Years
133%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Opyl Ltd
Glance View
Opyl Ltd. is an information technology company. The company is headquartered in St Kilda, Victoria. The firm is focused on executing the change in direction into digital health, rebuilding the research and development pipeline to deliver solutions for the global health and life sciences sector. The firm has built a Opin, which is clinical trial recruitment platform that leverages social media, search engine optimization technologies and artificial intelligence science, matching patients directly to clinical trials. The firm is also developing Clinical trial prediction and protocol design tool. The firm subsidiaries include ShareRoot Inc, ShareRoot (Australian Ops) Pty Ltd, Opyl Services and Ludomade, Inc.
See Also
What is Opyl Ltd's Operating Income?
Operating Income
-2.8m
AUD
Based on the financial report for Dec 31, 2024, Opyl Ltd's Operating Income amounts to -2.8m AUD.
What is Opyl Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-19%
Over the last year, the Operating Income growth was -11%. The average annual Operating Income growth rates for Opyl Ltd have been -4% over the past three years , -6% over the past five years , and -19% over the past ten years .
